TCR-MILS (U.S. Trademark Serial Number 90639572) is a United States trademark of WindMIL Therapeutics, Inc.. The goods and services include: pharmaceutical preparations and substances to provide immune activity to fight an existing disease; pharmaceutical preparations and substances, namely, preparations that involve removal, manipulation, activation, expansion and reintroduction of t-cells T cell therapy services; T cell therapy services, namely, providing adaptive cell therapy services; providing information in the field of cancer treatment; providing information in the field of treatment of cancer via a website; providing a website via a global computer network featuring information in the fields of health, cancer treatment, T cell therapy, immunology; medical services relating to the removal, treatment and processing of lymphocytes; medical services relating to the removal, treatment and processing of human cells cell therapy research and development services; cell therapy research services, namely, research concerning lymphocytes found in bone marrow; medical and scientific research in the fields of oncology, immunology, lymphocytes and T cells; research and development in the fields of oncology, immunology, lymphocytes, T cells; medical and scientific research, namely, conducting clinical trials for others in the fields of oncology, immunology, lymphocytes, and T cells; medical and scientific research in the field of cancer treatment. The correspondent is CAITLIN BYCZKO of BARNES & THORNBURG LLP.
This trademark was filed on April 12, 2021 as United States Trademark Application Serial Number 90639572. This trademark application is still pending and does not yet have a registration number.
Trademark PTO Status History
July 01, 2022 – PREVIOUS ALLOWANCE COUNT WITHDRAWN
July 01, 2022 – WITHDRAWN FROM PUB – SENIOR ATTORNEY REQUEST
June 30, 2022 – APPROVED FOR PUB – PRINCIPAL REGISTER
June 30, 2022 – EXAMINER’S AMENDMENT ENTERED
June 30, 2022 – NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
June 30, 2022 – EXAMINERS AMENDMENT E-MAILED
June 30, 2022 – EXAMINERS AMENDMENT -WRITTEN
June 27, 2022 – EXAMINER’S AMENDMENT ENTERED
View full trademark status information at USPTO
Ownership History
WindMIL Therapeutics, Inc.
View documents on file at USPTO
File a Trademark or Get Help With Trademark Law
Select IP monitors top trademarks which have been allowed and granted worldwide. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.